Effect of a goal-directed composite insulation scheme on perioperative elderly patients undergoing laparoscopic colorectal cancer surgery: study protocol for a randomized controlled trial Authors: Lingjun Du, Yanguang Su, Xieyuan Yu, Zhuhua Shen, Yanli Zhang, He Liu, Zhaozheng Zhen Published: 2025 ABSTRACT AbstractBackgroundTo explore the clinical effect and practical value of perioperative composite insulation scheme in elderly patients undergoing laparoscopic colorectal cancer surgery.MethodsIn this prospective, randomized, controlled trial, we will enroll 100 patients aged over 65 years, schemed for laparoscopic colorectal cancer surgery under general anesthesia. They will be randomly assigned to two groups: the conventional group will adopt the traditional insulation intervention, and the intervention group will implement the composite insulation care intervention. Changes in heart rate and blood pressure between immediately 15 and 30 min after surgery and the incidence of anesthesia recovery and complications between the two groups will be recorded and analyzed.DiscussionIt is expected that the perioperative composite insulation intervention strategy can effectively maintain the patient’s body temperature, reduce the postoperative stress response, and reduce the incidence of hypothermia and related complications. It can improve the surgical safety and the quality of postoperative recovery in elderly patients.Trial registrationChinese Clinical Trial Registry (https://www.chictr.org.cn/) ChiCTR2400088729. Registered in August, 2024. This trial is a prospective registry with the following registry names: Construction and application of perioperative goal-oriented composite insulation scheme in elderly patients undergoing laparoscopic colorectal cancer surgery.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13063-025-09367-8.Keywords: Composite insulation, Elderly, Laparoscope, Colorectal cancer, Perioperative period Administrative information Trials guidance: please include this text in your protocol just above the Administrative information table: Note: the numbers in curly brackets in this protocol refer to SPIRIT checklist item numbers. The order of the items has been modified to group similar items (see http://www.equator-network.org/reporting-guidelines/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/). Title {1}SPIRIT guidance: Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym.Trial registration {2a and 2b}.Chinese Clinical TrialRegistry, http:/www.chictr.org.cn,ID:ChiCTR2400088729,Registered on August 2024.Protocol version {3}Protocol Version 5.0 dated 21–10–2022. This research protocol is ascientific research project of Zhejiang Province medical and health science and technology plan project.The research protocol has undergone acomprehensive external peer review as part of the research projectreview process.Funding {4}This trial is funded by a grant from Zhejiang Provincial Medical and Health Science and Technology Project Fund (grant number 2023RC276 to LJD,The National Natural Science Foundation of China (NSFC82171227 and NSFC81300957 to HL),the Zhejiang Provincial Natural Science Foundation (LY22H090019 to HL),Open project fund of the Key Laboratory for NeuroInformation of Ministry of Education (202311KFY00102 to HL),Zhejiang Province cerebrovascular disease diagnosis and treatment of traditional Chinese medicine multidisciplinary innovation team project (to HL),An “Integration of Medicine, Industry and information” Collaborative Innovation Center Fund of Yangtze Delta Region Institute (Huzhou),University of Electronic Science and Technology of Chna—Huzhou Central Hospital(to HL).Author details {5a}Lingjun Du1, Yangguang Su1, Xieyuan Yu1, Zhuhua Shen1, Yanli Zhang1, He Liu2, Zhaozheng Zhen31Department of Anesthesia and Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China;2Department of Anesthesiology & Clinical Research Center for Anesthesia and Perioperative Medicine & Key Laboratory of Anesthesia and Analgesia Application Technology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China;3Department of Anorectal Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China.Roles·and·responsibilities:Principal investigator:LJD and YGSStudy design:LJD and YGSTrial coordination: YLZ. YXY and HLCollection of data:ZHS,and LJDPostoperative follow-up:YXY and ZZZData analysis and interpretation:YGSWriting of the manuscript: LJD and HLName and contact information for the trial sponsor {5b}Lingjun Du, Huzhou Central Hospital, Huzhou, ChinaE-mail:279236286@qq.com + 86–13819285084Role of sponsor {5c}This is an investigator-initiated trial. Lingjun Du is the sponsor of- this study and they were fully involved in planning and designing the study.The study design, data collection, data analysis, data- interpretation,manuscript writing or publication decisions are conducted independently from the funding agency.Composition of the coordinating center and trial steering committee {5d}This is a single-center trial and there will be no partner center or trial steering committee. The principal investigator will hold weekly study group meetings to discuss and analyze the progress of the study and report any serious events to the ethics committee. They will have no stakeholders or the private sector.Background and rationale {6a}This study intends to use a prospective, randomized controlled study to investigate whether the peroperative composite insulation strategy for elderly patients undergoing laparoscopic colorectal cancer surgery is more beneficial to reduce peroperative hypothermia, reduce postoperative complications and promote rapid postoperative recovery. The results of this study will provide a scientific theoretical basis for the standardized perioperative body temperature management of such patients, and will provide useful clinical guidance for their rapid postoperative rehabilitation.Explanation for the choice of comparators {6b}We describe all the interventions as composite insulation methods.Objectives {7}Planned to adopt a combination of preoperative and postoperative recovery insulation measures to protect patients with intraoperative temperature, and observe composite insulation measures and conventional insulation care measures in intraoperative low temperature, postoperative complications, anesthesia recovery time of clinical effect, clarify the intraoperative temperature timing and factors affecting temperature stability, test compound insulation method in elderly laparoscopic colorectal cancer patients to prevent intraoperative low temperature clinical effect and feasibility, and explore the elderly laparoscopic colorectal cancer to prevent the best temperature care measures.Trial design {8}The study will be conducted using a prospective, single-center, parallel-group, randomized, controlled trial.Study setting {9}This study will be conducted in colorectal cancer patients undergoing laparoscopic surgery at Huzhou Central Hospital, Zhejiang Province, China.Eligibility criteria {10}1.Age 65 years or older2.Indications for surgery and proposed laparoscopic colorectal cancer surgery3.Able and able to complete the investigator4.Anesthesia classification (ASA) is grade I-III5.Clinical data were complete6.Ability to understand the protocol and to sign the informed consent formIntervention description {11a}All subjects will wait in the preoperative preparation room at room temperature of 25℃, perform laparoscopic colorectal cancer surgery by the same surgeon, and resuscitate in the anesthesia resuscitation room at room temperature at room temperature at 22 to 24℃ and humidity at 50% to 60%. Use disinfectant, infusion liquid and irrigation solution warmed to 37℃; cover with quilt.Criteria for discontinuing or modifying allocated interventions {11b}1.The operation is transferred into the abdomen2.Innot insulation due to related device failure3.Postwas transferred to intensive care unit4.Withdrawal of consent5.Other serious perioperative adverse eventsStrategies to improve adherence to interventions {11c}We will fx a researcher to perform the pre-surgical assessment and sign the informed consent form.Relevant concomitant care permitted or prohibited during the trial {11d}All study participants will receive standard post-oper- ative care in the operating room, post-anaesthesia care unit (PACU) and wards.Outcomes {12}1.Time2.The incidence of postoperative chills.3.Thermal comfortParticipant timeline {13}Figure 1.Sample size {14} n=p01-p0ua+uβ2p-p02 Recruitment {15}The trial is currently in the recruitment stage。Sequence generation {16a}Random sequences were generated 1:1 using a computerized random number generator and placed in sealed, opaque, and sequentially numbered envelopes.Concealment mechanism {16b}The assigned intervention will be placed in sealed envelopes and marked with participant numbers, inconsistent with the order of randomization.Implementation {16c}After obtaining consent, a designated researcher will open the envelope and show the assigned intervention. Subsequently, the operators involved in the trial will perform the intervention.Who will be blinded {17a}The participants, investigators with postoperative follow-up will be unaware of the randomization sequence.Procedure for unblinding if needed {17b}The trial did not involve unblinding and follow an open-label design. Only the data analysts will be blinded.Plans for assessment and collection of outcomes {18a}The primary outcome of this trial is body temperature, and complete monitoring data for body temperature throughout the perioperative period will be derived using a repeater device (cHub, Beijing Ruiren Medical Company). Secondary outcomes will be obtained from the Anesthesia care system records.Plans to promote participant retention and complete follow-up {18b}Studies regarding purpose, procedure, duration, outcomes, potential benefits and risks will be provided to participants to ensure that their study understands that the study did not affect their treatment at any stage.Participants have the right to withdraw from the study at anytime for any reason. Reasons for withdrawal will be asked, measured and recorded in the source documents, and the Ethics Committee will be informed.Data management {19}A data monitoring team with an anesthesiologist, a statistician, and a nurse was formed.Statistical methods for primary and secondary outcomes {20a}SPSS 25.0 statistical softwareMethods for additional analyses (e.g. subgroup analyses) {20b}Not applicableMethods in analysis to handle protocol non-adherence and any statistical methods to handle missing data {20c}This is an interventional studyInterim analyses {21b}Not applicableWho will take informed consent? {26a}The eligibility of the participants will be determined by the anesthesiologist, anorectal surgeon and operating room nurse.Additional consent provisions for collection and use of participant data and biological specimens {26b}Not applicableConfidentiality {27}Strictly confidential all paper patient information will be stored in a secure safe during the trial.Provisions for post-trial care {30}Not applicableDissemination plans {31a}A clinical article will be written on the primary and secondary outcomes of the study, each article will be published in peer-reviewed journals related to geriatric care, gastrointestinal surgery, and the results will be disseminated regardless of size or direction impact.Plans to give access to the full protocol, participant-level data and statistical code {31c}This is a major investigator-initiated trial. Upon submission of a reasonable written request and obtaining authorization from the principal investigator, the full protocol, participant-level data and statistical code for study purposes will be considered.Plans for collection, laboratory evaluation and storage of biological specimens for genetic or molecular analysis in this trial/future use {33}Not applicableTitle {1}SPIRIT guidance: Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym.Trial registration {2a and 2b}.Chinese Clinical TrialRegistry, http:/www.chictr.org.cn,ID:ChiCTR2400088729,Registered on August 2024.Protocol version {3}Protocol Version 5.0 dated 21–10–2022. This research protocol is ascientific research project of Zhejiang Province medical and health science and technology plan project.The research protocol has undergone acomprehensive external peer review as part of the research projectreview process.Funding {4}This trial is funded by a grant from Zhejiang Provincial Medical and Health Science and Technology Project Fund (grant number 2023RC276 to LJD,The National Natural Science Foundation of China (NSFC82171227 and NSFC81300957 to HL),the Zhejiang Provincial Natural Science Foundation (LY22H090019 to HL),Open project fund of the Key Laboratory for NeuroInformation of Ministry of Education (202311KFY00102 to HL),Zhejiang Province cerebrovascular disease diagnosis and treatment of traditional Chinese medicine multidisciplinary innovation team project (to HL),An “Integration of Medicine, Industry and information” Collaborative Innovation Center Fund of Yangtze Delta Region Institute (Huzhou),University of Electronic Science and Technology of Chna—Huzhou Central Hospital(to HL).Author details {5a}Lingjun Du1, Yangguang Su1, Xieyuan Yu1, Zhuhua Shen1, Yanli Zhang1, He Liu2, Zhaozheng Zhen31Department of Anesthesia and Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China;2Department of Anesthesiology & Clinical Research Center for Anesthesia and Perioperative Medicine & Key Laboratory of Anesthesia and Analgesia Application Technology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China;3Department of Anorectal Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China.Roles·and·responsibilities:Principal investigator:LJD and YGSStudy design:LJD and YGSTrial coordination: YLZ. YXY and HLCollection of data:ZHS,and LJDPostoperative follow-up:YXY and ZZZData analysis and interpretation:YGSWriting of the manuscript: LJD and HLName and contact information for the trial sponsor {5b}Lingjun Du, Huzhou Central Hospital, Huzhou, ChinaE-mail:279236286@qq.com + 86–13819285084Role of sponsor {5c}This is an investigator-initiated trial. Lingjun Du is the sponsor of- this study and they were fully involved in planning and designing the study.The study design, data collection, data analysis, data- interpretation,manuscript writing or publication decisions are conducted independently from the funding agency. Chinese Clinical TrialRegistry, http:/www.chictr.org.cn, ID:ChiCTR2400088729,Registered on August 2024. This trial is funded by a grant from Zhejiang Provincial Medical and Health Science and Technology Project Fund (grant number 2023RC276 to LJD, The National Natural Science Foundation of China (NSFC82171227 and NSFC81300957 to HL), the Zhejiang Provincial Natural Science Foundation (LY22H090019 to HL), Open project fund of the Key Laboratory for NeuroInformation of Ministry of Education (202311KFY00102 to HL), Zhejiang Province cerebrovascular disease diagnosis and treatment of traditional Chinese medicine multidisciplinary innovation team project (to HL), An “Integration of Medicine, Industry and information” Collaborative Innovation Center Fund of Yangtze Delta Region Institute (Huzhou), University of Electronic Science and Technology of Chna—Huzhou Central Hospital(to HL). Lingjun Du1, Yangguang Su1, Xieyuan Yu1, Zhuhua Shen1, Yanli Zhang1, He Liu2, Zhaozheng Zhen3 1Department of Anesthesia and Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China; 2Department of Anesthesiology & Clinical Research Center for Anesthesia and Perioperative Medicine & Key Laboratory of Anesthesia and Analgesia Application Technology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China; 3Department of Anorectal Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China. Roles·and·responsibilities: Principal investigator:LJD and YGS Study design:LJD and YGS Trial coordination: YLZ. YXY and HL Collection of data:ZHS,and LJD Postoperative follow-up:YXY and ZZZ Data analysis and interpretation:YGS Writing of the manuscript: LJD and HL Lingjun Du, Huzhou Central Hospital, Huzhou, China E-mail:279236286@qq.com + 86–13819285084 1.Age 65 years or older 2.Indications for surgery and proposed laparoscopic colorectal cancer surgery 3.Able and able to complete the investigator 4.Anesthesia classification (ASA) is grade I-III 5.Clinical data were complete 6.Ability to understand the protocol and to sign the informed consent form 1.The operation is transferred into the abdomen 2.Innot insulation due to related device failure 3.Postwas transferred to intensive care unit 4.Withdrawal of consent 5.Other serious perioperative adverse events 1.Time 2.The incidence of postoperative chills. 3.Thermal comfort Studies regarding purpose, procedure, duration, outcomes, potential benefits and risks will be provided to participants to ensure that their study understands that the study did not affect their treatment at any stage. Participants have the right to withdraw from the study at anytime for any reason. Reasons for withdrawal will be asked, measured and recorded in the source documents, and the Ethics Committee will be informed. Chinese Clinical TrialRegistry, http:/www.chictr.org.cn, ID:ChiCTR2400088729,Registered on August 2024. This trial is funded by a grant from Zhejiang Provincial Medical and Health Science and Technology Project Fund (grant number 2023RC276 to LJD, The National Natural Science Foundation of China (NSFC82171227 and NSFC81300957 to HL), the Zhejiang Provincial Natural Science Foundation (LY22H090019 to HL), Open project fund of the Key Laboratory for NeuroInformation of Ministry of Education (202311KFY00102 to HL), Zhejiang Province cerebrovascular disease diagnosis and treatment of traditional Chinese medicine multidisciplinary innovation team project (to HL), An “Integration of Medicine, Industry and information” Collaborative Innovation Center Fund of Yangtze Delta Region Institute (Huzhou), University of Electronic Science and Technology of Chna—Huzhou Central Hospital(to HL). Lingjun Du1, Yangguang Su1, Xieyuan Yu1, Zhuhua Shen1, Yanli Zhang1, He Liu2, Zhaozheng Zhen3 1Department of Anesthesia and Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China; 2Department of Anesthesiology & Clinical Research Center for Anesthesia and Perioperative Medicine & Key Laboratory of Anesthesia and Analgesia Application Technology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China; 3Department of Anorectal Surgery, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University || Huzhou Central Hospital, The Affiliated Central Hospital Huzhou University || Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang Province, China. Roles·and·responsibilities: Principal investigator:LJD and YGS Study design:LJD and YGS Trial coordination: YLZ. YXY and HL Collection of data:ZHS,and LJD Postoperative follow-up:YXY and ZZZ Data analysis and interpretation:YGS Writing of the manuscript: LJD and HL Lingjun Du, Huzhou Central Hospital, Huzhou, China E-mail:279236286@qq.com + 86–13819285084 Introduction Background and rationale {6a} Colorectal cancer [1–3] (CRC) is the third most common cancer in the world. The incidence of colorectal cancer has risen to the third of malignant tumors and the first of digestive tract malignant tumors [4]. According to the latest statistics in China, the incidence rate and mortality rate of colorectal cancer in China rank the third and the fifth place, respectively, among malignant tumors (Hao Jie’s team). At present, surgery is still the first choice and the most important treatment mode for colorectal cancer. Nowadays, more and more elderly patients choose to perform endoscopic surgery for [5]. Advanced age and hypothermia are high risk factors for postoperative complications in such patients. Due to the low basal metabolic rate, weak thermoregulatory capacity and tolerance, decreased vasoconstriction threshold, and increased sensitivity to anesthetics, elderly patients have a higher risk of hypothermia and reduced body metabolism [6]. After the initiation of anesthesia induction, the patient’s body temperature is no longer regulated by the thermoregulatory center. When the patient’s intraoperative body temperature falls below 36 °C, it is considered intraoperative hypothermia. Clinically, hypothermia is categorized into three levels based on the temperature value: mild hypothermia (34~36 °C), moderate hypothermia (32~34 °C), and severe hypothermia (< 32 °C). It has been reported that the incidence of hypothermia in elderly patients can be as high as 74%, and there is a close correlation between lower preoperative functional status and adverse postoperative outcomes. Low temperature will cause damage to the body’s immune system, inhibit the killing of neutrophils, reduce white blood cells toward the infection movement, reduce the blood flow and skin oxygen supply, inhibit oxygen intake, chills, awakening delay, wound infection [7], affect platelet function, increase the incidence of heart disease, prolong the patient stay in PACU, serious cases can lead to metabolic acidosis, coagulation dysfunction, and multiple organ failure, thus seriously affect the patients with rapid postoperative rehabilitation [8]. In view of this, in order to accelerate the postoperative rehabilitation of elderly patients with colorectal cancer [9], avoiding perioperative hypothermia is an important part of the rapid postoperative recovery of such patients. Clinical investigation found that only 20% of patients with perioperative temperature monitoring, and the conventional insulation measures are mostly limited to passive insulation, and the application of active insulation measures is very limited. Inflatating blanket is the most commonly used and effective active insulation measure [10], which plays an important role in preventing perioperative hypothermia. In clinical practice, we observed that about 20% of patients still had perioperative hypothermia [11]; moreover, the effectiveness and utility of inflatable heating blanket in patients undergoing colorectal cancer surgery are not sufficient evidence. Therefore, this study intends to use a prospective, randomized controlled study to investigate whether the peroperative composite insulation strategy for elderly patients undergoing laparoscopic colorectal cancer surgery is more beneficial to reduce peroperative hypothermia, reduce postoperative complications, and promote rapid postoperative recovery. The results of this study will provide a scientific theoretical basis for the standardized perioperative body temperature management of such patients and will provide useful clinical guidance for their rapid postoperative rehabilitation. Objectives {7} Planned to adopt a combination of preoperative and postoperative recovery insulation measures to protect patients with intraoperative temperature, and observe composite insulation measures and conventional insulation care measures in intraoperative low temperature, postoperative complications, anesthesia recovery time of clinical effect, clarify the intraoperative temperature timing and factors affecting temperature stability, test compound insulation method in elderly laparoscopic colorectal cancer patients to prevent intraoperative low temperature clinical effect and feasibility, and explore the elderly laparoscopic colorectal cancer to prevent the best temperature care measures. Trial design {8} The study will be conducted using a prospective, single-center, parallel-group, randomized, controlled trial. Methods: participants, interventions, and outcomes Study setting {9} This study will be conducted in colorectal cancer patients undergoing laparoscopic surgery at Huzhou Central Hospital, Zhejiang Province, China. Eligibility criteria {10} The inclusion and exclusion criteria for participants in this study are as follows: Inclusion criteriaAge 65 years or olderIndications for surgery and proposed laparoscopic colorectal cancer surgeryAble and able to complete the investigatorAnesthesia classification (ASA) is grades I–IIIClinical data were completeAbility to understand the protocol and to sign the informed consent form Inclusion criteriaAge 65 years or olderIndications for surgery and proposed laparoscopic colorectal cancer surgeryAble and able to complete the investigatorAnesthesia classification (ASA) is grades I–IIIClinical data were completeAbility to understand the protocol and to sign the informed consent form Age 65 years or older Age 65 years or older Indications for surgery and proposed laparoscopic colorectal cancer surgery Indications for surgery and proposed laparoscopic colorectal cancer surgery Able and able to complete the investigator Able and able to complete the investigator Anesthesia classification (ASA) is grades I–III Anesthesia classification (ASA) is grades I–III Clinical data were complete Clinical data were complete Ability to understand the protocol and to sign the informed consent form Ability to understand the protocol and to sign the informed consent form Exclusion criteriaOperation time was less than 30 minRecent abnormal body temperatureSevere responders such as intraoperative bleeding and shockWith an abnormal coagulation function or abnormal liver and kidney functionPatients with basal metabolic abnormalitiesRefused to participate in this study Exclusion criteriaOperation time was less than 30 minRecent abnormal body temperatureSevere responders such as intraoperative bleeding and shockWith an abnormal coagulation function or abnormal liver and kidney functionPatients with basal metabolic abnormalitiesRefused to participate in this study Operation time was less than 30 min Operation time was less than 30 min Recent abnormal body temperature Recent abnormal body temperature Severe responders such as intraoperative bleeding and shock Severe responders such as intraoperative bleeding and shock With an abnormal coagulation function or abnormal liver and kidney function With an abnormal coagulation function or abnormal liver and kidney function Patients with basal metabolic abnormalities Patients with basal metabolic abnormalities Refused to participate in this study Refused to participate in this study Who will take informed consent? {26a} The eligibility of the participants will be determined by the anesthesiologist, anorectal surgeon, and operating room nurse. Each study participant will obtain written informed consent 1 day before the study starts so that participants will have enough time to consider and voluntarily choose to participate in this study. Additional consent provisions for collection and use of participant data and biological specimens {26b} Not applicable. No biological samples will be collected in this study. Interventions Explanation for the choice of comparators {6b} We describe all the interventions as composite insulation methods. Composite insulation method refers to the addition of preoperative pre-insulation, intraoperative insulation, and postoperative anesthesia resuscitation insulation measures on the basis of conventional insulation measures. Intervention description {11a} All subjects will wait in the preoperative preparation room at room temperature of 25 ℃, perform laparoscopic colorectal cancer surgery by the same surgeon, and resuscitate in the anesthesia resuscitation room at room temperature at room temperature at 22 to 24 ℃ and humidity at 50% to 60%. 37℃ disinfectant, intravenous infusion and peritoneal lavage fluid were used in the operation. Grouping random sequences were generated in a 1:1 order using a computerized random number generator, placed in sealed, opaque and sequentially numbered envelopes. When the participant is eligible for the study and assigned to surgery, the researcher will open the envelope to obtain a random sequence that determines the grouping. Each participant will correspond to a unique random serial number in the order in which they participate in this study. Numbering information for all participants will be recorded in the randomized list. Description for Intervention Eligible participants will be randomly assigned to the above two groups in the same proportion and will monitor the core body temperature using a wireless body temperature sensor (iThermonitor WT701 Beijing Ruiren Medical Company). The sensor is attached to the armpit and provides continuous (every 4 s) core body temperature monitoring, whose accuracy and accuracy have been confirmed in surgical patients [12]. The body temperature data is transmitted to the monitor and central temperature monitoring system via a signal repeater (cHub) manufactured by Beijing Rui Ren Medical Company. After the patient enters the surgical preparation room, the body temperature sensor will be fixed to either side of the axilla by using the adhesive tape of the instrument, and the upper arm is closed for 8 min. The monitoring time continues until the patient leaves the anesthesia recovery room (PACU). Routine group intervention methods: Adjust room temperature to 25 ℃ before operation, 22 ℃ after the operation, and humidity of 45%; use disinfectant, infusion liquid, and irrigation solution with heating to 37 ℃; provide insulation with quilt during the operation. Intervention group: During the waiting room, use inflatable insulation set to 40 ℃ for pre-insulation for 30 min; preoperative room temperature was adjusted to 25 ℃, 22 ℃ after the operation, 45% humidity; spread variable blanket on the operating table and set to 35 ℃; use the warmed to 37 ℃ disinfectant, infusion fluid, and irrigation fluid; cover the chest and abdomen with inflatable blanket for at least 20 min before anesthesia, and continuously cover the neck and chest during the operation; warm from CO2 to 37 ℃; use inflatable insulation 40 ℃ for 30 min. Introduction for investigators: The study will be conducted by the participation of the department of anesthesia, anorectal surgery, resuscitation room nurses, and surgery nurses. The nursing participants in this study had extensive experience in endoscopic colorectal surgical coordination and had specialized training in temperature monitoring. Criteria for discontinuing or modifying allocated interventions {11b} Research interventions have been identified. Once an intervention is implemented, it cannot be modified. The investigator will discontinue the participant if one of the following occurs during the course of the experiment: The operation is transferred into the abdomen. The operation is transferred into the abdomen. In not insulation due to related device failure. In not insulation due to related device failure. Post was transferred to intensive care unit. Post was transferred to intensive care unit. Withdrawal of consent. Withdrawal of consent. Other serious perioperative adverse events. Other serious perioperative adverse events. Strategies to improve adherence to interventions {11c} A researcher will be assigned to perform the preoperative assessment and sign the informed consent form. The researcher will conduct a pre-anaesthetic assessment the day before the procedure, with strict exclusion and inclusion criteria. During the process of obtaining informed consent from the participants, the researcher will explain in detail what the study is about and the need for cooperation. In addition, another researcher who is unaware of the grouping will administer a brief 3–5-min questionnaire to participants within 24 h of the procedure without unduly interrupting their rest time. Relevant concomitant care permitted or prohibited during the trial {11d} All study participants will receive standard post-operative care in the operating room, post-anaesthesia care unit (PACU), and wards. Provisions for post-trial care {30} Not applicable. After the trial, subjects will receive standard care per local policy. Outcomes {12} Primary outcome The primary outcome was the incidence of hypothermia. Axillary temperature serves as an observation indicator of core body temperature. During general anesthesia, measuring core body temperature via the middle and lower esophagus is the most common practice, while routine monitoring of esophageal temperature or nasopharyngeal temperature poses certain risks, such as severe gastroesophageal varices and skull base fractures. Although axillary temperature does not constitute core body temperature, it can reflect core body temperature to a certain extent. The relationship between axillary temperature and core body temperature largely depends on measurement techniques and environment. Compared to traditional axillary thermometers, the novel wireless temperature sensor used in this study provides better estimates of core body temperature. Its temperature probe continuously measures and records body temperature at a frequency of once every 4 s and compensates for errors caused by changes in environmental temperature and measurement location through algorithms. Before measurement, the axilla is thoroughly prepared to ensure sufficient contact between the wireless temperature probe and the axillary skin. Additionally, we chose to use temperature data obtained every 15 min as the observation indicator, mainly due to the discovery during the comparison of colorectal cancer surgery duration and temperature measurement points that measuring temperature every 15 min is the optimal choice in terms of economy, manpower, and material resources in the operating room. Therefore, when patients in the control group and intervention group enter the preoperative waiting area, they will be placed with a temperature probe connected to a multi-function monitor for continuous dynamic monitoring and recording of their body temperature at various time points, including room temperature (T1), preoperative temperature (T2), temperature at 30 min during surgery (T3), temperature at 60 min during surgery (T4), temperature at 90 min during surgery (T5), temperature at the end of surgery (T6), temperature upon entering the post-anesthesia care unit (PACU) (T7), and temperature upon exiting the PACU (T8). Secondary outcomes Time Observe and record the anesthesia time (i.e., from anesthesia induction from awake to sleep to emergence from anesthesia) in the observation group, the operation time (from the beginning of the surgeon and the end of the incision), the removal time (from the end of the procedure to the indication and the removal of the catheter) (the stay time in the anesthesia room (PACU) (the time between the patient and the ward). The incidence of postoperative chills The incidence of postoperative chills in the observation group and the trial group (after recovery from surgical anesthesia to the resuscitation room was recorded). In this study, Wrench Level 4 assessment method was used to evaluate the occurrence of chills: observe whether muscle fibrillation occurred in the face and neck muscles, and affected the ECG waveform in the ECG monitor, which was mild chills; the limb muscles had obvious muscle fibrillation and moderate chills; the whole body had obvious tremor, which was severe chills. If the above three situations occur, no chills occurs. Thermal comfort The thermal comfort score of patients was evaluated using the thermal comfort score method (Numerical rating scale, NRS) of German scholars Perl et al. The method totaled 10 points; 0 to 10 represent different thermal comfort conditions. After the patient explains the evaluation method, the day after the procedure was scored and recorded according to the patient’s feedback. The primary reason for measuring thermal comfort on the second day after surgery in this study is that patients are not fully conscious post-operation and thus unable to fully understand and respond to the questions posed. The digital thermal comfort scale scoring method developed by German scholar Perl has been clinically applied in China and demonstrates good reliability and validity, enabling accurate measurement of patients’ evaluations of thermal comfort during heat preservation. Participant timeline {13} The participant schedule is shown in Fig. 1. Time schedule of enrollment interventions, assessments and visits for participants. Preoperative preparation room. PACU postanaesthesi changing blanket Inflatabe Insulating Blanket Temperature monitoring; NRS Sample size {14} The sample content required for this test is calculated according to the sample size formula. Among them, P represents the sample rate, that is, the proportion of the number of people with hypothermia in the observed research subjects, and P0 represents the proportion of the phenomenon of hypothermia in the total number of units. P0 = 54%, P = 34.8%, α = 0.05, U0.05 = 1.6449, β = 0.20, U0.20 = 0.841, n = 41.642 in the formula, considering that about 10% follow-up during the study included at least 47 patients in the control group and intervention group. Recruitment {15} Our hospital provides healthcare services to over 4 million people in the surrounding area. More than 280 laparoscopic colorectal cancer procedures were performed annually, and recruitment for the study will begin in September 2023 and is expected to continue until October 2025. Sufficient patient source was available to ensure completion of the recruitment of 94 eligible participants. The trial is currently in the recruitment stage, and patients will be screened according to strict recruitment criteria. The expected participants will be obtained from the surgical waiting list. Screening will be completed by reviewing their health records to determine eligibility. Patients will be recruited after admission and 1 day before surgery. Assignment of interventions: allocation Sequence generation {16a} Random sequences were generated 1:1 using a computerized random number generator and placed in sealed, opaque, and sequentially numbered envelopes. When the participant is eligible for the study and is allowed to enter the surgery preparation room, the researcher will open the envelope and obtain a randomized sequence that group grouping. Each participant will correspond to a unique random serial number in an envelope in the order they participate in this study. Numbering information for all participants will be recorded in the randomized list. Concealment mechanism {16b} The assigned intervention will be placed in sealed envelopes and marked with participant numbers, inconsistent with the order of randomization. Implementation {16c} After obtaining consent, a designated researcher will open the envelope and show the assigned intervention. Subsequently, the operators involved in the trial will perform the intervention. Assignment of interventions: blinding Who will be blinded {17a} Due to the nature of the intervention in this study, the person responsible for the randomization process and the operator of the insulation measures will be unblinded to the researcher. Therefore, participants, investigators with postoperative follow-up will be unaware of the randomization sequence. Procedure for unblinding if needed {17b} The trial did not involve unblinding and follow an open-label design. Only the data analysts will be blinded. Data collection and management Plans for assessment and collection of outcomes {18a} The primary outcome of this trial is body temperature, and complete monitoring data for body temperature throughout the perioperative period will be derived using a repeater device (cHub, Beijing Ruiren Medical Company). Secondary outcomes will be obtained from the Anesthesia care system records. Plans to promote participant retention and complete follow-up {18b} Studies regarding purpose, procedure, duration, outcomes, potential benefits, and risks will be provided to participants to ensure that their study understands that the study did not affect their treatment at any stage. Participants have the right to withdraw from the study at anytime for any reason. Reasons for withdrawal will be asked, measured, and recorded in the source documents, and the Ethics Committee will be informed. Data management {19} The study will manage the data according to the Data Security Law of the People’s Republic of China and the General Data Protection Regulation [13] of the European Union of Nations. Follow the principles of “clear purpose” and “minimum collection.” All study data will be exported by the Do care system and then transcribed into Microsoft Excel by researchers who are not involved in the implementation of the intervention and who will aggregate the data and analyze them using stationary computers. To improve the quality and accuracy of the data, a data monitoring team with an anesthesiologist, a statistician, and a nurse was formed. Checking all data errors and those suspected data errors was revalidated. Access to security and computers is limited to researchers assigned to data entry, processing, and analysis work. Confidentiality {27} Strictly confidential all paper patient information will be stored in a secure safe during the trial. All electronic information relating to the study will be stored on the computer. To protect participant privacy, any access to the safe and computer will be critically reviewed and authorized. Study information from participants may not be used for purposes other than the study without written permission. Anonymized trial data can only be shared with other researchers with the consent of the authors and are used for research purposes only. Plans for collection, laboratory evaluation, and storage of biological specimens for genetic or molecular analysis in this trial/future use {33} Not applicable. No biological samples will be collected for this study. Statistical methods Statistical methods for primary and secondary outcomes {20a} Data analysis will be performed using SPSS 25.0 statistical software. Quantitative data were presented as mean ± standard deviation, and between-group and within-group comparisons were performed by t-test and repeated measures ANOVA; count data were presented as frequency and percentage and tested for between-group comparisons using χ2. Interim analyses {21b} Not applicable; an interim analysis was not performed in this study. Methods for additional analyses (e.g., subgroup analyses) {20b} Not applicable, and no additional analyses are planned for this study. Methods in analysis to handle protocol non-adherence and any statistical methods to handle missing data {20c} This is an interventional study where we will explain the intervention in detail and highlight collaborative matters to patients during pre-anesthesia assessment and obtaining informed consent and we suspect that few patients will be less compliant to the protocol. If the data is missing, we will complete the dataset using multiple compensation methods recommended by statistical expert Hsu et al. [14] and evaluate its effect by sensitivity analysis. We anticipate that very few patients will be lost to follow-up due to the nature of the clinical practice of the current trial intervention. Plans to give access to the full protocol, participant-level data and statistical code {31c} This is a major investigator-initiated trial. Upon submission of a reasonable written request and obtaining authorization from the principal investigator, the full protocol, participant-level data, and statistical code for study purposes will be considered. Oversight and monitoring Composition of the coordinating center and trial steering committee {5d} This is a single-center trial and there will be no partner center or trial steering committee. The principal investigator will hold weekly study group meetings to discuss and analyze the progress of the study and report any serious events to the ethics committee. They will have no stakeholders or the private sector. Composition of the data monitoring committee, its role and reporting structure {21a} We wish to complete the clinical intervention trial quickly; there is no evidence of significant safety issues with this study intervention, participants not participating in specific disease groups or life-threatening conditions, so no dedicated data monitoring committee will be established. The “data monitoring team” involved in item 19 is responsible for verifying the source documents and possible adverse events, whose membership and the verification process will be independent of the study process. Adverse event reporting and harms {22} The possible adverse reactions in this study are low temperature scald, and once the temperature monitoring finds more than 37 ℃, the variable blanket warming will be stopped immediately. Frequency and plans for auditing trial conduct {23} Nurses who do not participate in this trial will serve as independent reviewers during the trial. Independent review was performed every 2 weeks or every 10 newly recruited participants. All errors will be recorded and reported to the principal investigator. This audit will include a review of the CRF content, missing data, duplicate data, incorrect data, and informed consent documents. Plans for communicating important protocol amendments to relevant parties (e.g., trial participants, ethical committees) {25} The Ethics committee has reviewed the protocol of this study and has agreed to implement the study protocol. No modifications to the study protocol will be made without permission from the Ethics committee. If it is indeed necessary to modify the protocol, it should be reviewed by the principal investigator with a written request for modification and a written request submitted to the Ethics committee for further review and approval. Dissemination plans {31a} Following standard protocol guidelines, the authors indicated that unblinded data from this trial will not be available until the primary outcome is published. Unblinding will be performed at the end of the study. A clinical article will be written on the primary and secondary outcomes of the study; each article will be published in peer-reviewed journals related to geriatric care, gastrointestinal surgery, and the results will be disseminated regardless of size or direction impact. Discussion Under the comprehensive influence of various factors, the operation will lead to hypothermia [15], while the physiological function and temperature autoregulation ability of elderly patients are weakened, and the incidence of hypothermia is higher. Studies have shown that the incidence of hypothermia in surgery is 50%~90% [7]. If it is not corrected in time for a long time, it will cause surgical stress reaction, inhibit coagulation and immune function [16], and also lead to a decrease in the metabolism rate of anesthetic drugs and delay postoperative recovery, which is not conducive to postoperative rehabilitation [17]. Therefore, it is very important to prevent the occurrence of intraoperative hypothermia. Several studies have shown that the implementation of thermal insulation measures can maintain the intraoperative body temperature and hemodynamic stability of surgical patients, relieve the stress response, reduce the incidence of intraoperative hypothermia, and improve the recovery quality of patients [18, 19]. Therefore, the perioperative thermal insulation intervention has received clinical attention. The composite insulation strategy is based on evidence-based medicine, with comprehensive insulation intervention from multiple links and aspects. This study formulated a composite insulation measure based on the expert consensus of perioperative hypothermia prevention and carried out comprehensive insulation intervention through internal environment and external environment. In conclusion, our trial will reveal the influencing factors of body temperature changes in the elderly patients undergoing endoscopic colorectal cancer surgery, which is expected to maintain intraoperative body temperature stability and reduce the incidence of hypothermia. Trial status The trial is registered with the China Clinical Trials Registry (http://www.chictr.org.cn) identifer: ChiCTR2200061935. The current agreement is version 5.0 on October 21, 2022. Recruitment for this trial will begin in October 2022, and we are currently recruiting patients. Recruitment will be completed by approximately October 2025. Supplementary Information Additional file 1. Preoperative, Intraoperative, and postoperative CRFs. Additional file 2. Informed consent form. Additional file 3. Thermal comfort rating scale. Acknowledgements We would like to thank our operating theater colleagues for their strong support and assistance in this trial; the cooperation and assistance of our anorectal surgeons, anesthesiologists, and the anesthesia recovery room; and the ethics committee for modifying the informed consent form. Finally, we would like to thank all participants for their willingness to participate and collaborate in this trial. Abbreviations Colorectal cancer American Society of Anesthesiologists Post‑anaesthesia care unit Inadvertent perioperative hypothermia Case record form Authors’ contributions {31b} As the principal investigator, LJD conceived and designed the trial, wrote the initial proposal, and was, ultimately, responsible for the trial. HL contributed to the study design, supervised the proposal submission, and made substantial contributions to the revision of the foreign newspaper manuscript. The SMS reflected the content of the manuscript under the guidance of HL and submitted the ethical review and clinical registry. YLZ and YXY contributed to the coordination of the trial. ZHS and LJD were involved in the data collection. Postoperative follow-up was performed with YXY and ZZZ. SYG contributed to the analysis and interpretation of the data. All authors have made substantial contributions to this study and have approved this protocol. Authorship will be determined by their contribution to this trial. Funding {4} This trial has received partial support from grants provided by the Zhejiang Provincial Medical and Health Science and Technology Project Fund (grant number 2023RC276 to LJD), the National Natural Science Foundation of China (NSFC82171227 and NSFC81300957 to HL), the Zhejiang Provincial Natural Science Foundation (LY22H090019 to HL), open project fund of the Key Laboratory for NeuroInformation of Ministry of Education (202311KFY00102 to HL), Zhejiang Province cerebrovascular disease diagnosis and treatment of traditional Chinese medicine multidisciplinary innovation team project (to HL), and “Integration of Medicine, Industry and information” Collaborative Innovation Center Fund of Yangtze Delta Region Institute (Huzhou), University of Electronic Science and Technology of Chna—Huzhou Central Hospital(to HL). The funding agency’s involvement does not extend to influencing the study design, data collection, data analysis, data interpretation, manuscript writing, or publication decisions. Data availability {29} All data from this study are available from the corresponding author upon reasonable request and are used for research purposes only. Declarations Ethics approval and consent to participate {24} This study was approved by the Ethics Committee of Huzhou Central Hospital on November 1, 2022, with approval number 202209014–01. The study team will obtain written informed consent from each study participant. Consent for publication {32} The model informed consent form for this study is provided in the additional file 2. Written consent and consent for publication were obtained from all authors and participants. Competing interests {28} The authors declare that they have no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Lingjun Du, Yanguang Su and He Liu contributed equally to this work. References Associated Data Supplementary Materials Additional file 1. Preoperative, Intraoperative, and postoperative CRFs. Additional file 2. Informed consent form. Additional file 3. Thermal comfort rating scale. Data Availability Statement All data from this study are available from the corresponding author upon reasonable request and are used for research purposes only.